Skip to main content

Closed

SNDX: Syndax Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

59thpctl

Volume

0.61×avg

Market Cap

1.69BUSD

P/E Ratio

-6.8TTM

Div Yield

-ann

Syndax Pharmaceuticals, Inc.

SNDXNASDAQ Global Select·USD·Closed

Syndax Pharmaceuticals, Inc.

SNDXNASDAQ·USD·Closed

$19.05

−2.21%

$19.05

−$0.43 (2.21%)

52W Range

59thpctl

Volume

0.61×avg

Mkt Cap

1.69BUSD

P/E

-6.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings